These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32056928)

  • 1. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Lee H; Song M; Lee J; Kim JB; Lee MS
    J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
    Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder.
    Guo J; Zhang T; Chen W; Tan J; Li X; Zheng A; Fu Y; Qiu T
    BMC Psychiatry; 2024 Apr; 24(1):285. PubMed ID: 38627683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster speed of onset of the depressive episode is associated with lower cytokine serum levels (IL-2, -4, -6, -10, TNF-α and IFN-γ) in patients with major depression.
    Buspavanich P; Adli M; Himmerich H; Berger M; Busche M; Schlattmann P; Bopp S; Bschor T; Richter C; Steinacher B; Stoppel C; Hindinger C; Meyer S; Hoffmann K; Stamm T; Gabriel A; Merkl A; Goerke-Arndt F; Köhler S; Sterzer P; Heinz A; Behr J; Fakhri H; Lang F; Lang UE; Ricken R
    J Psychiatr Res; 2021 Sep; 141():287-292. PubMed ID: 34271459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Qiu T; Li X; Chen W; He J; Shi L; Zhou C; Zheng A; Lei Z; Tang C; Yu Q; Du L; Guo J
    Front Psychiatry; 2023; 14():1132791. PubMed ID: 37009097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
    Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression.
    Gabbay V; Klein RG; Guttman LE; Babb JS; Alonso CM; Nishawala M; Katz Y; Gaite MR; Gonzalez CJ
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):423-30. PubMed ID: 19702494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
    Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
    J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
    Zou W; Feng R; Yang Y
    PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder.
    Lan X; Zhou Y; Wu F; Wu K; Zhan Y; Wang C; Zheng W; Yu M; Deng X; Ning Y
    J Affect Disord; 2021 May; 287():327-333. PubMed ID: 33813252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder.
    Liu L; Yang X; Yang C; Tian Y; Li W; Xia L; Liu H
    J Affect Disord; 2024 Apr; 350():110-117. PubMed ID: 38220096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune system dysregulation in adolescent major depressive disorder.
    Gabbay V; Klein RG; Alonso CM; Babb JS; Nishawala M; De Jesus G; Hirsch GS; Hottinger-Blanc PM; Gonzalez CJ
    J Affect Disord; 2009 May; 115(1-2):177-82. PubMed ID: 18790541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in heart rate variability in first-episode drug-naïve adolescents with major depressive disorder: A 12-week prospective study.
    Park SW; Lee JH; Kim J; Suh S; Lee MS
    J Affect Disord; 2018 Oct; 238():250-255. PubMed ID: 29890452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
    Dahl J; Ormstad H; Aass HC; Malt UF; Bendz LT; Sandvik L; Brundin L; Andreassen OA
    Psychoneuroendocrinology; 2014 Jul; 45():77-86. PubMed ID: 24845179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study.
    Pérez-Sánchez G; Becerril-Villanueva E; Arreola R; Martínez-Levy G; Hernández-Gutiérrez ME; Velasco-Velásquez MA; Alvarez-Herrera S; Cruz-Fuentes C; Palacios L; de la Peña F; Pavón L
    Mediators Inflamm; 2018; 2018():4074051. PubMed ID: 30662368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
    Mao R; Zhang C; Chen J; Zhao G; Zhou R; Wang F; Xu J; Yang T; Su Y; Huang J; Wu Z; Cao L; Wang Y; Hu Y; Yuan C; Yi Z; Hong W; Wang Z; Peng D; Fang Y
    J Affect Disord; 2018 Sep; 237():65-72. PubMed ID: 29778935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder.
    Chen CY; Yeh YW; Kuo SC; Liang CS; Ho PS; Huang CC; Yen CH; Shyu JF; Lu RB; Huang SY
    Psychoneuroendocrinology; 2018 Jan; 87():108-118. PubMed ID: 29055264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
    Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
    Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.